[{"NetIncomeLoss_1_Q1_USD":-7077000.0,"TreasuryStockCommonShares_0_Q1_shares":121500.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-261000.0,"Depreciation_1_Q1_USD":44000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":269000.0,"AssetsCurrent_0_Q1_USD":51356000.0,"LongTermDebt_0_Q1_USD":2076000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":10658317.0,"TreasuryStockValue_0_Q1_USD":48000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":261000.0,"CommonStockSharesIssued_0_Q1_shares":188277852.0,"Assets_0_Q1_USD":53847000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1528000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":28125000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":1.73,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":261000.0,"LiabilitiesNoncurrent_0_Q1_USD":3077000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":277000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GeneralAndAdministrativeExpense_1_Q1_USD":4185000.0,"PaymentsOfFinancingCosts_1_Q1_USD":0.0,"FinanceLeasePrincipalPayments_1_Q1_USD":6000.0,"CommonStockValue_0_Q1_USD":1883000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q1_USD":4954000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":405000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":300000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":2872000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":26297000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":1822000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":2703000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-7077000.0,"OtherAssetsNoncurrent_0_Q1_USD":1578000.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":44792000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1375000.0,"Liabilities_0_Q1_USD":7358000.0,"OperatingLeaseLiability_0_Q1_USD":1539000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":186298122.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-493000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-7057000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":252000.0,"LiabilitiesCurrent_0_Q1_USD":4281000.0,"AccountsPayableCurrent_0_Q1_USD":1040000.0,"NonoperatingIncomeExpense_1_Q1_USD":-20000.0,"InterestExpense_1_Q1_USD":20000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":44943000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1576000.0,"SeveranceCosts1_1_Q1_USD":300000.0,"LongTermDebtNoncurrent_0_Q1_USD":1702000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":134000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.046,"StockIssued1_1_Q1_USD":4988000.0,"AdditionalPaidInCapital_0_Q1_USD":125032000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":44000.0,"ShortTermBorrowings_0_Q1_USD":374000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":762000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-5283000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":833000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":226000.0,"RestrictedCashNoncurrent_0_Q1_USD":151000.0,"OperatingLeaseCost_1_Q1_USD":68000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":53847000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":336000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":833000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":9300000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":988000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":164000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1800000.0,"OperatingExpenses_1_Q1_USD":7057000.0,"StockholdersEquity_0_Q1_USD":46489000.0,"AdvancesOnInventoryPurchases_0_Q1_USD":4988000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":261000.0,"VariableLeaseCost_1_Q1_USD":30000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-80379000.0,"LeaseCost_1_Q1_USD":98000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":20753000.0,"CommonStockSharesOutstanding_0_Q1_shares":188156352.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.04,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":163000.0,"Ticker":"OCGN","CIK":"1372299","name":"OCUGEN, INC.","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]